Page last updated: 2024-08-23

raloxifene hydrochloride and Hypocalcemia

raloxifene hydrochloride has been researched along with Hypocalcemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stepan, JJ; Zikan, V1
Jerums, G; MacIsaac, RJ; Seeman, E; Varadarajan, S; Vu, TD1

Trials

1 trial(s) available for raloxifene hydrochloride and Hypocalcemia

ArticleYear
Marked reduction of bone turnover by alendronate attenuates the acute response of bone resorption marker to endogenous parathyroid hormone.
    Bone, 2009, Volume: 44, Issue:4

    Topics: Aged; Aged, 80 and over; Alendronate; Area Under Curve; Biomarkers; Bone Density Conservation Agents; Bone Remodeling; Bone Resorption; Chelating Agents; Collagen Type I; Edetic Acid; Etidronic Acid; Female; Humans; Hypocalcemia; Middle Aged; Osteoporosis, Postmenopausal; Parathyroid Hormone; Peptides; Raloxifene Hydrochloride; Risedronic Acid

2009

Other Studies

1 other study(ies) available for raloxifene hydrochloride and Hypocalcemia

ArticleYear
Hypocalcemia induced by raloxifene.
    Current drug safety, 2012, Volume: 7, Issue:2

    Topics: Aged, 80 and over; Bone Density Conservation Agents; Female; Humans; Hypocalcemia; Mass Screening; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Vitamin D Deficiency

2012